1. Home
  2. COCO vs SRPT Comparison

COCO vs SRPT Comparison

Compare COCO & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

HOLD

Current Price

$76.29

Market Cap

3.0B

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$16.59

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCO
SRPT
Founded
2004
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
COCO
SRPT
Price
$76.29
$16.59
Analyst Decision
Buy
Hold
Analyst Count
9
29
Target Price
$57.75
$25.85
AVG Volume (30 Days)
1.6M
2.6M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
26.60
N/A
EPS
0.50
2.88
Revenue
N/A
$2,198,237,000.00
Revenue This Year
$16.12
N/A
Revenue Next Year
$11.40
N/A
P/E Ratio
$151.99
$5.85
Revenue Growth
N/A
15.58
52 Week Low
$31.82
$10.42
52 Week High
$79.99
$43.92

Technical Indicators

Market Signals
Indicator
COCO
SRPT
Relative Strength Index (RSI) 67.16 32.33
Support Level $50.99 $15.70
Resistance Level $79.99 $19.62
Average True Range (ATR) 2.73 1.01
MACD -0.16 -0.35
Stochastic Oscillator 68.57 1.51

Price Performance

Historical Comparison
COCO
SRPT

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: